Daniel Ambruso, MD

Provider's Specialties

Hematology/Oncology - Pediatric

Provider's location(s)

Anschutz Medical Campus, Aurora

View map

Patient ratings

Patient ratings and reviews are not available

Why?

Center for Cancer and Blood Disorders

(720)777-6740

Insurance plans accepted

We participate with most major health insurance plans and national transplant networks.

View the full list

Prepare for your visit

We want to make sure you know what to expect before you arrive.

See the checklist

Get to know Daniel Ambruso, MD

Departments and Programs

Conditions Treated

Blood Disorders
Bleeding Disorders

Languages spoken

English

Experience and background

I am interested in Qualitative and Quantitative Disorders of Neutrophils, Allo and Autoimmune Disorders of Red Cells and Platelets, General Hematology and Transfusion Medicine.

Undergraduate 1969

Georgetown University (DC)

Medical Education 1973

University of Rochester School of Medicine and Dentistry

Internship 1973

Case Western Reserve University (MetroHealth) Program

Residency 1976

Case Western Reserve University (MetroHealth) Program

Fellowship 1978

University of Colorado

Fellowship 1979

National Jewish Medical and Research Center

Website: http://www.ncbi.nlm.nih.gov/pubmed?term="Ambruso DR"[Author]

For Patients:
I am interested in Neutrophil Function in the Following Clinical Groups: Thermal Injury and Trauma Patients; Newborn Patients; Patients with Absence of Specific Granules; Patients with Glycogenosis lb; and Patients with Chronic Granulomatous Disease. I, also, focus on Chronic Transfusion Therapy and Iron Overload in Patients with Chronic Anemia. Additionally, I am interested in Antibody-Mediated Disorders of Platelets and Neutrophils, as well as the Generation of Lysophosphatidylcholines in Stored Blood Components and their relationship to the Pathophysiology of Transfusion Related Acute Lung Injury (TRALI).

For Referring Providers:
I am interested in the Respiratory Burst Activity and Bactericidal Activity of Neutrophils and Monocytes. Additionally, I focus on the Priming Mechanisms of Neutrophil Oxidase and the Development of Clinical Models of Excess Inflammation. I, also, concentrate on Blood Component Storage and Pathogen Reduction, as well as the Counting of Residual Leukocytes in Leukoreduced Blood Components. I collaborate with COBE BCT to develop new equipment and systems to separate platelets from whole blood. Additionally, I am interested in Alloimmunization in Response to Red Cell and Platelet Transfusions.